SCHW
62
-2
PYPL
54
2
JPM
69
2
RL
72
4
BK
74
2
EFX
38
2
BSX
67
-3
NKE
36
6
UA
50
-9
UPS
60
9
PEP
48
6
CFG
70
6
KMB
39
2
DG
6
2
EBAY
47
4
ZION
65
2
CPB
30
6
GT
62
6
LH
43
-2
JWN
48
6
SCHW
62
-2
PYPL
54
2
JPM
69
2
RL
72
4
BK
74
2
EFX
38
2
BSX
67
-3
NKE
36
6
UA
50
-9
UPS
60
9
PEP
48
6
CFG
70
6
KMB
39
2
DG
6
2
EBAY
47
4
ZION
65
2
CPB
30
6
GT
62
6
LH
43
-2
JWN
48
6
Financhill
Back

Anebulo Pharmaceuticals 10K Form

Sell
38

ANEB
Anebulo Pharmaceuticals

Last Price:
1.59
Seasonality Move:
20.03%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ANEB News And Ratings

See the #1 stock for the next 7 days that we like better than ANEB

ANEB Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-1.69M
Price / Cash Flow: 0
Annual Sales: $0.07
Price / Book: 19.94

Profitability

EPS (TTM): -0.30000
Net Income (TTM): $-7.92M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Anebulo Pharmaceuticals Earnings Forecast

Key Anebulo Pharmaceuticals Financial Ratios

  • The Interest Expense is -1.84% of Operating Income.
  • Per Share Earnings over the last 4 years have been positive in 2 years.

Anebulo Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: ANEB
Website: anebulo.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ANEB Technical Analysis vs Fundamental Analysis

Sell
38
Anebulo Pharmaceuticals (ANEB) is a Sell

Is Anebulo Pharmaceuticals a Buy or a Sell?